Ixekizumab (Anti-CTLA-8 / IL-17a)
Ixekizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD<3 pM). Ixekizumab has the potential to be used in research on plaque psoriasis. MW: 146.44 KD.
Trivial name | LY2439821 |
Catalog Number | A2862 |
CAS# | 1143503-69-8 |
Size | 1mg*5 |